🇺🇸 FDA
Patent

US 12310997

Compositions and methods of treating ocular diseases

granted A61KA61K35/761A61K48/0041

Quick answer

US patent 12310997 (Compositions and methods of treating ocular diseases) held by The Regents of the University of California expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/761, A61K48/0041, A61K48/0075, A61K9/0048